Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VIKS-2A / VIKS-2B vitamin K supplementation in patients starting vitamin K antagonists
2007-004578-15Phase 4Active
- Sponsor
- Nederlandse Hartstichting
- Start
- Nov 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in None comparing Vitamin K supplementation with Placebo (2 arms). Primary endpoint: Complications of treatment with vitamin K antagonists. Started Nov 2007; status: active.
02
Drugs
phytomenadione
Beyond the preview
Go deeper on 2007-004578-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004578-15.